600739.SH
Liaoning Cheng Da Co., Ltd.
SSE · Healthcare · Medical - Distribution · CN
CNY 9.75
+0.00%Oct 16, 2026, 06:25 UTC
Liaoning Chengda said it will deepen strategic cooperation with GF Securities and China United Insurance Group Co., Ltd. to strengthen support from its financial investment segment for its industrial businesses.
Source:Sep 22, 2026, 02:21 UTC
Chengda Biological's first batch of human diploid rabies vaccine was shipped from its Benxi subsidiary and launched to market on September 15, 2026.
Source:Sep 2, 2026, 09:14 UTC
Liaoning Chengda Co., Ltd., a shareholder holding more than 5% of GF Securities, completed the issuance of a 1 billion yuan exchangeable bond (first tranche) to professional institutional investors.
Source:Aug 30, 2026, 07:39 UTC
Liaoning Chengda announced its 2026 first-half results with revenue of 4.411 billion yuan, down 13.56% year-on-year, and net profit attributable to shareholders of 1.620 billion yuan, up 125.77% year-on-year.
Source:Jul 7, 2026, 08:36 UTC
Liaoning Chengda's shareholder Guangxi Xinyixin and its concert parties extended the repurchase date for a portion of pledged shares and pledged additional shares.
Source: